Moreover, analyses of The Cancer Genome Atlas (TCGA) database showed that LNMAT1 was significantly overexpressed in various types of human cancer, such as bladder, prostate, kidney, colon, lung, and liver cancer (Supplementary Fig. 2a–f), and LNMAT1 overexpression correlated with LN metastasis (Supplementary Fig. 2g–h) and poor prognosis in human cancers, including thyroid carcinoma, kidney cancer, colon carcinoma, and liver cancer (Supplementary Fig. 2i–p), which further suggested that LNMAT1 may play an oncogenic role in progression and development of various human cancer types. The gene discussed is DUXAP9; the disease is kidney cancer.